These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 17763135)

  • 1. Vogt-Koyanagi-Harada syndrome in children: report of a case and review of the literature.
    Berker N; Ozdamar Y; Soykan E; Ozdal P; Ozkan SS
    Ocul Immunol Inflamm; 2007; 15(4):351-7. PubMed ID: 17763135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of pediatric Vogt-Koyanagi- Harada (VKH)-associated panuveitis.
    Soheilian M; Aletaha M; Yazdani S; Dehghan MH; Peyman GA
    Ocul Immunol Inflamm; 2006 Apr; 14(2):91-8. PubMed ID: 16597538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple agent immunosuppressive therapy in Vogt-Koyanagi-Harada syndrome.
    Agarwal M; Ganesh SK; Biswas J
    Ocul Immunol Inflamm; 2006 Dec; 14(6):333-9. PubMed ID: 17162603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, clinical characteristics, and causes of vision loss in children with Vogt-Koyanagi-Harada disease in South India.
    Martin TD; Rathinam SR; Cunningham ET
    Retina; 2010; 30(7):1113-21. PubMed ID: 20168275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vogt-Koyanagi-Harada disease: clinical outcomes.
    Bykhovskaya I; Thorne JE; Kempen JH; Dunn JP; Jabs DA
    Am J Ophthalmol; 2005 Oct; 140(4):674-8. PubMed ID: 16226518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vogt-koyanagi-harada syndrome.
    Fang W; Yang P
    Curr Eye Res; 2008 Jul; 33(7):517-23. PubMed ID: 18600484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic regimen in Vogt-Koyanagi-Harada syndrome].
    Yang P; Wang H; Zhou H; Zhong H; Li F; Huang X; Zhong H; Fu T
    Zhonghua Yan Ke Za Zhi; 2002 Apr; 38(4):196-9. PubMed ID: 12133384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vogt-Koyanagi-Harada syndrome in a case of multiple sclerosis.
    Montero JA; Sanchis ME; Fernandez-Munoz M
    J Neuroophthalmol; 2007 Mar; 27(1):36-40. PubMed ID: 17414871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vogt-Koyanagi-Harada disease.
    Damico FM; Kiss S; Young LH
    Semin Ophthalmol; 2005; 20(3):183-90. PubMed ID: 16282153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vogt-Koyanagi-Harada disease in Thai patients.
    Tesavibul N; Sansanayuth W
    J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S26-30. PubMed ID: 16681048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first-line therapy.
    Paredes I; Ahmed M; Foster CS
    Ocul Immunol Inflamm; 2006 Apr; 14(2):87-90. PubMed ID: 16597537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanin-laden macrophages in the CSF to diagnose Vogt-Koyanagi-Harada simulating ocular syphilis.
    Kim LA; Khurana RN; Parikh JG; Rao NA
    Ocul Immunol Inflamm; 2008; 16(1):59-61. PubMed ID: 18379946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease.
    Lai TY; Chan RP; Chan CK; Lam DS
    Eye (Lond); 2009 Mar; 23(3):543-8. PubMed ID: 18369377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal quantification of aqueous flare and cells in Vogt-Koyanagi-Harada disease.
    Fang W; Zhou H; Yang P; Huang X; Wang L; Kijlstra A
    Br J Ophthalmol; 2008 Feb; 92(2):182-5. PubMed ID: 17965105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vogt-Koyanagi-Harada disease in children.
    Abu El-Asrar AM; Al-Kharashi AS; Aldibhi H; Al-Fraykh H; Kangave D
    Eye (Lond); 2008 Sep; 22(9):1124-31. PubMed ID: 17479116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Band-shaped keratopathy in Chinese patients with Vogt-Koyanagi-Harada syndrome.
    Yang P; Sun M
    Cornea; 2011 Dec; 30(12):1336-40. PubMed ID: 21934492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab therapy for 2 patients with Vogt-Koyanagi-Harada syndrome.
    Wang Y; Gaudio PA
    Ocul Immunol Inflamm; 2008; 16(4):167-71. PubMed ID: 18716952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Vogt-Koyanagi-Harada disease by corticosteroids and immunosuppressive agents.
    Rao NA
    Ocul Immunol Inflamm; 2006 Apr; 14(2):71-2. PubMed ID: 16597535
    [No Abstract]   [Full Text] [Related]  

  • 19. Vogt-Koyanagi-Harada disease: diagnosis and treatments update.
    Bordaberry MF
    Curr Opin Ophthalmol; 2010 Nov; 21(6):430-5. PubMed ID: 20829689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vogt-Koyanagi-Harada syndrome: glucocorticoid therapy and visual prognosis].
    Zhang M; Liu Q; Min H; Du H; Hu T
    Zhonghua Yan Ke Za Zhi; 2002 Apr; 38(4):200-3. PubMed ID: 12133385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.